Skip to main content
. 2014 Mar 28;4(3):e197. doi: 10.1038/bcj.2014.14

Figure 3.

Figure 3

General immune effector cells are not affected by 5-Azacytidine treatment in vivo. The number and reactivity of NK cells and CD8 and CD4 T cells are shown. First cycle represents a sample obtained before treatment. (a, c, e) absolute peripheral blood counts of CD8 and CD4 T cells and CD3CD56+CD16+/− NK cells, respectively. (b, d, f) Expression of CD107a on CD8 and CD4 T cells and NK cells, respectively, in response to SEB (for T cells) or to K562 cells (for NK cells).